Lifeline Biotechnologies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LLBO research report →
Price Chart
About the company
Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases.
- CEO
- Caren Currier
- IPO
- 1995
- HQ
- Reno, NV, US
Get TickerSpark's AI analysis on LLBO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.74M
- P/E
- -51.58
- PEG
- -0.52
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -51.58
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.00%
- ROIC
- 0.00%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-58,304
- Net Income
- $-58,304-905.2%
- EPS
- $0.00+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -3.53
- RSI (14)
- 47
- Avg Volume
- 419.98K
No earnings-call transcripts are available for LLBO yet.
- Free Float
- 59.3%
- Shares Outstanding
- 4.35B
- Float Shares
- 2.58B
Our LLBO coverage
Recent articles, reports, and earnings notes.
No research on LLBO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LLBO report →